29.17 USD
▲-0.11+4.48%
盘后 27.93 +0.04%
2026-08-03
市值
$550.41M
市盈率
—
EPS
-4.46
股息率
—
52 周区间
14.39 – 39.53
成交量
145.91K
Beta
0.10
目标价
78.44
52W 低 14.3952W 高 39.53
价格走势
公司简介
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPC...